Skip to content
sellWeak

Gilead Raday sold $1,574 of RDHL

Chief Operating Officer at RedHill Biopharma Ltd.. 15,740,000 shares at an average of $0.00, traded Apr 6, 2026, filed Apr 22, 2026.

Warning score
5
Value
$1,574
15,740,000 shares
Holdings after
261,060,000
-6% from before
From 52-week low
+11%
low $0.75, close $0.83
From 52-week high
-70%
high $2.78, as of Apr 6, 2026

Score components

  • Role
    COO
    +20
  • Trade size
    $2k at market
    0
  • Share of holdings sold
    Sold 5.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

RDHLOct 12, 2026 · close 0.53
Since filing Apr 22, 2026: -37.1%SPY +10.0% · excess -47.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001178913-26-002183, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 6, 2026SOpen-market sale
Ordinary Shares
-15,740,000$0.00$1,574261,060,000Apr 22, 2026
Apr 6, 2026MOption exercise
American Depositary Sharesderivative
+30,780,000$0.00$076,150,000Apr 22, 2026

Related signals

Other insiders at RedHill Biopharma Ltd. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
5Weak
RDHLsell
RedHill Biopharma Ltd.
Gilead Raday
Chief Operating Officer
$1,431
14,310,000 shares
-7%
5Weak
RDHLsell
RedHill Biopharma Ltd.
Gilead Raday
Chief Operating Officer
$1,413
14,130,000 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gilead Raday sold $1,574 of RDHL | InsiderTell